Zhan Zhang

发表

Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer

H. Mankin, Xianzhe Liu, Z. Duan, 2010, Clinical Cancer Research.

Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.

H. Mankin, Xianzhe Liu, Wei-Qin Yuan, 2012, Journal of medicinal chemistry.

Interleukin-6 signaling pathway in targeted therapy for cancer.

Z. Duan, Yuqi Guo, Zhan Zhang, 2012, Cancer treatment reviews.

CILP Inhibits Brain Metastasis by Meditating Mast Cells via the MAPK Signaling Pathway in Breast Cancer

Yingchao Liu, Qiang Wang, A. Feng, 2021 .

Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats

H. Mankin, Yan Gao, Z. Duan, 2016, Scientific Reports.

Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats

Edwin, Yan Gao, Z. Duan, 2016, Scientific Reports.

Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P‐glycoprotein and enhancing apoptosis

H. Mankin, Yan Gao, Z. Duan, 2015, International journal of cancer.

Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma

H. Mankin, J. Schwab, Z. Duan, 2013, PloS one.

NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.

Yan Gao, Z. Duan, F. Hornicek, 2015, Gynecologic oncology.

Silencing the Double-Stranded RNA Binding Protein DGCR8 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion

L. Pfeffer, Hongwei Li, J. Yue, 2013, Pharmaceutical Research.

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

Z. Duan, F. Hornicek, D. Harmon, 2014, British Journal of Cancer.